Targeting Tumor Microenvironment for Cancer Therapy
Open accessThe DOI matches its Crossref record; 209 of the 212 references it cites were found in a registry or an index.
Abstract
Cancer development is highly associated to the physiological state of the tumor microenvironment (TME). Despite the existing heterogeneity of tumors from the same or from different anatomical locations, common features can be found in the TME maturation of epithelial-derived tumors. Genetic alterations in tumor cells result in hyperplasia, uncontrolled growth, resistance to apoptosis, and metabolic shift towards anaerobic glycolysis (Warburg effect). These events create hypoxia, oxidative stress and acidosis within the TME triggering an adjustment of the extracellular matrix (ECM), a response from neighbor stromal cells (e.g., fibroblasts) and immune cells (lymphocytes and macrophages), inducing angiogenesis and, ultimately, resulting in metastasis. Exosomes secreted by TME cells are central players in all these events. The TME profile is preponderant on prognosis and impacts efficacy of anti-cancer therapies. Hence, a big effort has been made to develop new therapeutic strategies towards a more efficient targeting of TME. These efforts focus on: (i) therapeutic strategies targeting TME components, extending from conventional therapeutics, to combined therapies and nanomedicines; and (ii) the development of models that accurately resemble the TME for bench investigations, including tumor-tissue explants, “tumor on a chip” or multicellular tumor-spheroids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Main properties of in vitro 2D and 3D culture systems [187,188]. CAF, Cancer-associated fibroblast; ECM, Extracellular matrix.](https://figures.cochat.ai/paper-figures/5beab1962bf5470fbdf9b87661e2bff6/targeting-tumor-microenvironment-for-cancer-therapy-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dense ECM, abnormal vasculature, and an acidified environment all contribute to decreased drug penetration [83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared to the microenvironment of healthy tissue, the TME has augmented deposition of proteins such as collagen and fibronectin, high cytokine levels, increased proportion of fibroblasts and immune cells, and is immunosuppressive [82,83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“agents that degrade and/or deconstruct the ECM should be used cautiously, as they may lead to the release of factors that promote tumor progression and induce metastasis [83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Concerning the therapeutic outcome of such drugs, although they showed to improve patient survival, it has not been as great as expected, mostly related to the fact that patients stop responding or do not respond at all to these therapies, or even due to the side effects, for instance, the increased risk of arterial t…”
BackgroundElements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352 · cited 1×
“While some tumors present few signals of inflammation, others show a high number of immune cells either at the periphery or infiltrated within the tumor [70,71].”
BackgroundMacrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 3×
“Epithelial tumors display common features that allow for the setting of hallmarks that define cancer progression [7,8].”
BackgroundTumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“For this reason, tumors are frequently regarded as “wounds that never heal” [7,92].”
BackgroundTumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Research works printed but not linked: 1
- Larson B. 3D cell culture: A review of current techniques BioTek 2015 6 1 10
Cited by
Items 501–600 of 1,000
Cell Analysis on Microfluidics Combined with Mass Spectrometry
Zhang, W., Zhang, Q., & Lin, J. (2020) · Analytical Sciences · doi:10.2116/analsci.20r006 · Cited by 18
Combining Oncolytic Viruses and Small Molecule Therapeutics: Mutual Benefits
Spiesschaert, B., Angerer, K., Park, J., & Wollmann, G. (2021) · Cancers · doi:10.3390/cancers13143386 · Cited by 22
Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery
de Sousa, E., Lérias, J. R., López-Beltrán, A., Paraschoudi, G., Condeço, C., Kamiki, J., António, P., Figueiredo, N., Carvalho, C. T., Castillo-Martín, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.592031 · Cited by 19
Simón, L., Sanhueza, S., Gaete‐Ramírez, B., Varas‐Godoy, M., & Quest, A. F. G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.897205 · Cited by 20
Complexity of Tumor Microenvironment: Therapeutic Role of Curcumin and Its Metabolites
Prasad, S., Saha, P., Chatterjee, B., Chaudhary, A. A., Lall, R., & Srivastava, A. K. (2022) · Nutrition and Cancer · doi:10.1080/01635581.2022.2096909 · Cited by 21
Krishna, A. V. S. S., Ramu, A., Hariharan, S., Sinha, S., & Donakonda, S. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107433 · Cited by 19
A Gas Nanobomb to Promote Drug Penetration and Amplify TACE Therapy for Orthotopic Liver Tumor
Chen, M., Lu, Q., Gong, F., Yang, Y., Pei, Z., Huang, X., Shu, G., Shen, L., Peng, Y., Guo, X., et al. (2025) · Advanced Materials · doi:10.1002/adma.202505770 · Cited by 24
Jairath, N. K., Farha, M. W., Srinivasan, S., Jairath, R., Green, M. D., Dess, R. T., Jackson, W., Weiner, A. B., Schaeffer, E. M., Zhao, S. G., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061973 · Cited by 18
The effect of interleukin‐17F on vasculogenic mimicry in oral tongue squamous cell carcinoma
Almahmoudi, R., Salem, A., Hadler‐Olsen, E., Svineng, G., Salo, T. A., & Al‐Samadi, A. (2021) · Cancer Science · doi:10.1111/cas.14894 · Cited by 20
Prognostic value of tumour microenvironment‐related genes by TCGA database in rectal cancer
Li, C., Liu, T., Liu, Y., Zhang, J., & Zuo, D. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16547 · Cited by 22
Sekar, R., Basavegowda, N., Thathapudi, J. J., Sekhar, M. R., Joshi, P., Somu, P., & Baek, K.-H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020433 · Cited by 21
Michaelidou, K., Agelaki, S., & Mavridis, K. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1724785 · Cited by 17
Deng, Q., Hua, A., Zhao, Q., Zhang, Z., Yang, T., Wang, Q., Yang, X., & Li, Z. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123501 · Cited by 19
A pyroptosis-related gene signature for prognostic and immunological evaluation in breast cancer
Zhong, Y., Peng, F., Luo, X., Wang, X., Yang, B., Tang, X., Zheng, X., Ren, L., Wang, Z., Peng, C. Y., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.964508 · Cited by 17
Rafik, S. T., Vaidya, J. S., MacRobert, A. J., & Yaghini, E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072648 · Cited by 17
Breusa, S., Zilio, S., Catania, G., Bakrin, N., Kryza, D., & Lollo, G. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1125868 · Cited by 18
Li, A., Ji, B., Yang, Y., Ye, B., Zhu, Q., Hu, X., Liu, Y., Zhou, P., Liu, J., Gao, R., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1164448 · Cited by 18
Identifying the oncogenic roles of FAP in human cancers based on systematic analysis
Ma, C., Xi, S., Sun, H., Zhang, M., & Pei, Y. (2023) · Aging · doi:10.18632/aging.204892 · Cited by 19
Gelbach, P. E., & Finley, S. D. (2023) · iScience · doi:10.1016/j.isci.2023.107569 · Cited by 16
Zhang, Q., Lou, Y., Fang, H., Sun, S., Jin, R., Ji, Y., & Chen, Z. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12438 · Cited by 21
Zhang, Y., Zou, W., Dou, W., Luo, H., & Ouyang, X. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1377329 · Cited by 19
Tumor-derived extracellular vesicle proteins as new biomarkers and targets in precision oncology
Liao, H., Zhang, C., Wang, F., Jin, F., Zhao, Q., Wang, X., Wang, S., & Gao, J. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02452-6 · Cited by 19
Wu, H., Jin, M., Liu, Y., Wang, S., Liu, C., Quan, X., Jin, M., Gao, Z., & Jin, Y. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124625 · Cited by 16
Liu, Y., Kong, L., Yu, Y., Zang, J., Zhang, L., Guo, R., Li, S., Cheng, L., Li, X., & Chen, Y.-Q. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s470219 · Cited by 16
Wang, Y., Su, H., Yan, M., Zhang, L., Tang, J., Li, Q., Gu, X., & Gong, Q. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.595053 · Cited by 16
Are radiomics features universally applicable to different organs?
Lee, S.-H., Cho, H.-H., Kwon, J., Lee, H. Y., & Park, H. (2021) · Cancer Imaging · doi:10.1186/s40644-021-00400-y · Cited by 19
Uprety, B., Chandran, R., Arderne, C., & Abrahamse, H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14010211 · Cited by 16
Zhu, B., Lv, X., Zhang, M., Wang, H., Chen, S., & Zhu, J. (2022) · Biomaterials Science · doi:10.1039/d1bm01806j · Cited by 18
Ambre, P., Gupta, C. R., Naik, I., Menon, M., & Coutinho, E. C. (2022) · Current Drug Delivery · doi:10.2174/1567201819666220408095510 · Cited by 19
Shen, X. P., Zhong, J., He, J., Han, J., & Chen, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.978092 · Cited by 16
Lu, Z., Yan, J., Xu, M., Sun, L., Liu, J., Zhang, Y., Shi, L., Fei, X., Cao, Y., & Pei, R. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.2c03850 · Cited by 16
The role of nanotherapy in head and neck squamous cell carcinoma by targeting tumor microenvironment
Zhang, Y., Dong, P., & Yang, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1189323 · Cited by 22
Privat‐Maldonado, A., & Bogaerts, A. (2020) · Cancers · doi:10.3390/cancers12092617 · Cited by 16
Torna, S., Gkretsi, V., & Stylianou, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178588 · Cited by 19
Potential Regulatory Roles of GRK2 in Endothelial Cell Activity and Pathological Angiogenesis
Kuai, J., Han, C., & Wei, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.698424 · Cited by 15
Rerouting the drug response: Overcoming metabolic adaptation in KRAS-mutant cancers
Moss, D., McCann, C. K., & Kerr, E. M. (2022) · Science Signaling · doi:10.1126/scisignal.abj3490 · Cited by 18
Kumar, A., Kumar, B., & Bhatia, R. (2023) · Assay and Drug Development Technologies · doi:10.1089/adt.2022.120 · Cited by 16
Vahabi, M., Comandatore, A., Centra, C., Blandino, G., Morelli, L., & Giovannetti, E. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.11.003 · Cited by 15
Kobayashi, T., Noma, K., Nishimura, S., Kato, T., Nishiwaki, N., Ohara, T., Kunitomo, T., Kawasaki, K., Akai, M., Komoto, S., et al. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0527 · Cited by 18
Smart delivery vehicles for cancer: categories, unique roles and therapeutic strategies
Zeng, Y., Gao, Y., He, L., Ge, W., Wang, X., Ma, T., & Xie, X.-Y. (2024) · Nanoscale Advances · doi:10.1039/d4na00285g · Cited by 16
Peng, H., Wang, D., Huang, S., & Yu, A. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.01.065 · Cited by 15
Farahani, M., Rezaei–Tavirani, M., Zali, H., Hatamie, S., & Ghasemi, N. (2020) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36923 · Cited by 15
Overcoming Hypoxia-Induced Chemoresistance in Cancer Using a Novel Glycoconjugate of Methotrexate
Woźniak, M., Pastuch-Gawołek, G., Makuch, S., Wiśniewski, J. Ł., Ziolkowski, P. P., Szeja, W., Krawczyk, M., & Agrawal, S. (2020) · Pharmaceuticals · doi:10.3390/ph14010013 · Cited by 19
Hußtegge, M., Hoang, N. A., Rebstock, J., Monecke, A., Gockel, I., Weimann, A., Schumacher, G., Bechmann, I., Lordick, F., Kallendrusch, S., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1960729 · Cited by 17
Zhu, L., Yang, F., Li, X., Li, Q., & Zhong, C. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.743133 · Cited by 16
Cai, D., Zhao, Z., Hu, J., Dai, X., Zhong, G., Gong, J., & Qi, F. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.836080 · Cited by 17
Transcription factor Fli-1 as a new target for antitumor drug development
Li, L., Yu, J. H., Cheng, S., Peng, Z., & Luo, H. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.04.076 · Cited by 17
Lian, J., Zhang, C., & Lu, H. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/6284540 · Cited by 17
The metabolic crosstalk between PIN1 and the tumour microenvironment
Caligiuri, I., Canzonieri, V., Asano, T., Kumar, V., & Rizzolio, F. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.03.001 · Cited by 16
Chauhan, A., Agarwal, S., Masih, M., & Gautam, P. K. (2023) · Immunological Investigations · doi:10.1080/08820139.2023.2249025 · Cited by 17
Harguindey, S., Alfarouk, K. O., Orozco, J. D. P., Hardonnière, K., Stanciu, D., Fais, S., & Devesa, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031110 · Cited by 16
Breast Mammographic Density: Stromal Implications on Breast Cancer Detection and Therapy
Fernández‐Nogueira, P., Mancino, M., Fuster, G., Bragado, P., de Puig, M. P., Gascón, P., Casado, F. J., & Carbó, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030776 · Cited by 15
Exosomal circRNA in Digestive System Tumors: The Main Player or Coadjuvants?
Wang, H., Zeng, X., Zheng, Y., Wang, Y., & Zhou, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.614462 · Cited by 16
Guo, X., Li, Y., Wan, B., Lv, Y., Wang, X., Liu, G., & Wang, P. (2023) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.22-47 · Cited by 14
Zhao, Y., Li, R., Wang, W., Zhang, H., Zhang, Q., Jiang, J., Wang, Y., Li, Y., Guan, F., & Nie, Y. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217101 · Cited by 16
Zhang, Y., Gong, S., & Liu, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1483595 · Cited by 20
The Two Sides of Dietary Antioxidants in Cancer Therapy
Akanji, M. A., Fatinukun, H. D., Rotimi, D. E., Afolabi, B. L., & Adeyemı, O. S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.94988 · Cited by 24
Limam, I., Aissa‐Fennira, F. B., Essid, R., Chahbi, A., Kefi, S., Hammi, K. M., Elkahoui, S., & Abdelkarim, M. (2021) · Environmental Toxicology · doi:10.1002/tox.23090 · Cited by 15
lin, J. X., Wu, C., Ma, D., & Hu, Q. (2021) · PeerJ · doi:10.7717/peerj.11319 · Cited by 18
Oncogenic Role of Exosomal Circular and Long Noncoding RNAs in Gastrointestinal Cancers
Yun, B. D., Choi, Y. J., Son, S. W., Cipolla, G. A., Berti, F. C. B., Malheiros, D., Oh, T., Kuh, H. J., Choi, S. Y., & Park, J. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020930 · Cited by 14
Modulation of Type I Interferon Responses to Influence Tumor-Immune Cross Talk in PDAC
Cattolico, C., Bailey, P., & Barry, S. T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.816517 · Cited by 18
The Prognostic Value and Immunological Role of STEAP1 in Pan‐Cancer: A Result of Data‐Based Analysis
Zhao, C., Xiong, K., Ji, Z., Liu, F., & Li, X. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8297011 · Cited by 15
Cytokine Interaction With Cancer-Associated Fibroblasts in Esophageal Cancer
Hassan, S., Cwidak, N., Awasthi, N., & von Holzen, U. W. (2022) · Cancer Control · doi:10.1177/10732748221078470 · Cited by 14
Zheng, G., Liu, M., Chang, X., Cao, X., Dong, A., Zhu, H., Hu, W., Xie, J., Zhao, Y., Hu, D., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.888173 · Cited by 14
Su, Z., Wang, C., Pan, R., Li, H., Chen, J., Tan, J., Tian, X., Lin, T., & Shen, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1028263 · Cited by 16
The application of carbon dots in tumor immunotherapy: Researches and prospects
Cai, H., Abbas, K., Yang, Y., Li, Z., & Bi, H. (2023) · Applied Research · doi:10.1002/appl.202300001 · Cited by 14
Lung cancer organoids: models for preclinical research and precision medicine
Liu, Y., Zhou, Y., & Chen, P. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1293441 · Cited by 22
Naik, G. A. R. R., Rachana, S. P., Jadhav, S. R., Pokale, R., Hedayat, P., Datta, D., Prajapati, B. G., Mutalik, S., & Dhas, N. L. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00007 · Cited by 16
Wang, Y., Ye, Z., Yuan, Y., Wang, C., Chen, G., & Zhang, Y. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189464 · Cited by 12
Darzi, A., Shokouhfar, M., Farajee, N., Ghafari, A., Deldar, F., Eini, P., Vanan, A. G., & Bahrami, N. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118875 · Cited by 15
Lamichhane, A., Thakuri, P. S., Nejad, P. R., & Tavana, H. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211014185 · Cited by 13
Li, L., Ma, H., Li, D., Shu, Q., Wang, T., Song, X., & Xu, H. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116246 · Cited by 13
Adoptive neoantigen-reactive T cell therapy: improvement strategies and current clinical researches
Huang, R., Bi, Z., Hu, S., Zhang, Q., Su, X., & Zhang, W. (2023) · Biomarker Research · doi:10.1186/s40364-023-00478-5 · Cited by 16
Xu, Y., Han, J., Zhang, X., Zhang, X., Song, J., Gao, Z., Qian, H., Jin, J., & Liang, Z. (2023) · Oncology Reports · doi:10.3892/or.2023.8678 · Cited by 14
Mukerjee, N., Alharbi, H. M., Maitra, S., Anand, K., Thorat, N. D., & Gorai, S. (2023) · The Journal of Liquid Biopsy · doi:10.1016/j.jlb.2023.100134 · Cited by 13
Zhang, Q., Luo, Y., Qian, B., Cao, X., Xu, C., Guo, K., Wan, R., Jiang, Y., Wang, T., Mei, Z., et al. (2024) · Aging · doi:10.18632/aging.205800 · Cited by 23
Kong, L., Yu, Y., Yang, R., Guo, R., Zhang, L., Wang, J., Liu, Y., Zang, J., Yang, C., Yang, H.-Y., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.154173 · Cited by 13
König, J., Rokavec, M., Öner, M. G., Fei, Y., & Hermeking, H. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01380-9 · Cited by 15
Optimization of Antiproliferative Properties of Triimine Copper(II) Complexes
Choroba, K., Zowiślok, B., Kula, S., Machura, B., Maroń, A. M., Erfurt, K., Marques, C., Cordeiro, S. Z., Baptista, P. V., & Fernandes, A. R. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01806 · Cited by 14
Self-citationBiomolecular condensates: A new lens on cancer biology
Jiang, L., & Kang, Y. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189245 · Cited by 15
Wang, R., Li, W., Cao, H., & Zhang, L. (2025) · Biology · doi:10.3390/biology14030243 · Cited by 17
Mitrakas, A. G., Kakouratos, C., Lamprou, I., Xanthopoulou, E. T., & Koukourakis, M. I. (2025) · Cancers · doi:10.3390/cancers17050853 · Cited by 15
Extracellular vesicle cross-talk in the liposarcoma microenvironment
Casadei, L., & Pollock, R. E. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.04.026 · Cited by 14
Genomic, Immunological, and Clinical Characterization of Pyroptosis in Ovarian Cancer
Zhou, M., Li, B., Liu, J., & Li, H. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s344554 · Cited by 15
Hsu, F., Tsai, C.-L., Chiang, I., Lan, K., Yueh, P., Liang, W., Lin, C., Chao, Y., & Lan, K. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17220 · Cited by 14
Xie, B., Meng, Q., Yu, H., Shen, K., Cheng, Y., Dong, C., & Zhou, H. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114506 · Cited by 14
M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors
Barceló, C., Sisó, P., de la Rosa, I., Megino‐Luque, C., Navaridas, R., Maiques, Ó., Urdanibia, I., Eritja, N., Soria, X., Potrony, M., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01886-4 · Cited by 13
Evolving therapeutic proteins to precisely kill cancer cells
Zaman, R., Islam, R. A., & Chowdhury, E. H. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.066 · Cited by 13
Jiménez, M. C., Prieto, K., Lasso, P., Gutiérrez, M., Rodríguez-Pardo, V. M., Susana Fiorentino, G., & Barreto, A. (2022) · Heliyon · doi:10.1016/j.heliyon.2023.e14148 · Cited by 13
Su, Z., Linnebacher, C. S., & Linnebacher, M. (2023) · Cancers · doi:10.3390/cancers15072065 · Cited by 13
Therapies Targeting Immune Cells in Tumor Microenvironment for Non-Small Cell Lung Cancer
Ye, W., Li, M., & Luo, K.-W. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071788 · Cited by 15
RNAscope dual ISH–IHC technology to study angiogenesis in diffuse large B-cell lymphomas
Annese, T., Tamma, R., Giorgis, M. D., Ruggieri, S., Maiorano, E., Specchia, G., & Ribatti, D. (2019) · Histochemistry and Cell Biology · doi:10.1007/s00418-019-01834-z · Cited by 15
Gu, C., Zhang, Y., Chen, D., Liu, H., & Mi, K. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112725 · Cited by 15
Guo, J., Wang, C., Tang, H., Sang, B., Liu, X., Yi, F., & Wu, X. (2022) · Cell Biology International · doi:10.1002/cbin.11780 · Cited by 15
Genetically modified cell spheroids for tissue engineering and regenerative medicine
Jiang, Z., Xu, Y., Fu, M., Zhu, D., Li, N., & Yang, G. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.033 · Cited by 14
Jia, F., Li, Y., Gao, Y., Wang, X., Lu, J., Cui, X., Pan, Z., Xu, C., Deng, X., & Wu, Y. L. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122850 · Cited by 12
Advances of Protein Palmitoylation in Tumor Cell Deaths
Lin, X., Shi, Y.-X., Zhan, Y., Xing, Y., Li, Y., Zhou, Z., & Chen, G. (2023) · Cancers · doi:10.3390/cancers15235503 · Cited by 14
The implications for urological malignancies of non-coding RNAs in the the tumor microenvironment
Wang, S., Qi, X., Liu, D., Xie, D., Jiang, B., Wang, J., Wang, X., & Wu, G. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.12.016 · Cited by 13
Li, Y., Ren, X., Gao, W., Cai, R., Wu, J., Liu, T., Chen, X., Jiang, D., Chen, C., Cheng, Q., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14729 · Cited by 13
Beyond stiffness: deciphering the role of viscoelasticity in cancer evolution and treatment response
Zubiarrain-Laserna, A., Martínez‐Moreno, D., de Andrés, J. L., de Lara-Peña, L., Guaresti, O., Zaldua, A. M., Jiménez, G., & Marchal, J. A. (2024) · Biofabrication · doi:10.1088/1758-5090/ad5705 · Cited by 18
Metadata
- Authors
- Roma-Rodrigues, C., Mendes, R., Baptista, P. V., & Fernandes, A. R.
- Affiliations
- UCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa. Campus de Caparica, 2829-516 Caparica, Portugal
- Universidade Nova de Lisboa (PT)
- Corresponding author
- Baptista, Pedro V.
- Fernandes, Alexandra R.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-02-15
- Volume
- 20
- Issue
- 4
- Pages
- 840
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6413095
- OpenAlex
- W2913062750
- Cited by
- 1,187
- References
- 212
- Citations by year
- 2026: 76 · 2025: 134 · 2024: 156 · 2023: 229 · 2022: 186 · 2021: 216 · 2020: 139 · 2019: 47
- FWCI
- 14.04
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- Ministério da Ciência, Tecnologia e Ensino Superior (UID/Multi/04378/2019, SFRH/BPD/124612/2016)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- tumor microenvironment, cancer therapy, Warburg effect, tumor hypoxia, oxidative stress, extracellular matrix, tumor stromal cells, tumor-associated macrophages, angiogenesis, metastasis, exosomes, nanomedicine, combination therapy, tumor models, tumor-on-a-chip, tumor spheroids
- MeSH terms
- Animals, Humans, Models, Biological, Neoplasms, Neovascularization, Pathologic, Nanomedicine, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.